A pharmacoepidemiologic study of community-dwelling, disabled older women: Factors associated with medication use

American Journal Geriatric Pharmacotherapy

Volumn 8, Issue 3, 2010, Pages 215-224

  Crentsil, Victor ^a   Ricks, Michelle O ^a   Xue, Qian Li ^a   Fried, Linda P ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Columbia University ^*  (United States)

Author keywords

Disability; Elderly; Medication use; Pharmacoepidemiology; Women

Indexed keywords

ACETYLSALICYLIC ACID; ALUMINUM HYDROXIDE; ASCORBIC ACID; CALCIUM CARBONATE; DIGOXIN; DILTIAZEM; FUROSEMIDE; GLYCERYL TRINITRATE; HYDROCHLOROTHIAZIDE; IBUPROFEN; IRON; LEVOTHYROXINE; MAGNESIUM OXIDE; MULTIVITAMIN; NIFEDIPINE; NON PRESCRIPTION DRUG; PARACETAMOL; POTASSIUM CHLORIDE; RANITIDINE; TRIAMTERENE; PRESCRIPTION DRUG;

AFRICAN AMERICAN; AGED; ANGINA PECTORIS; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMMUNITY LIVING; CONGESTIVE HEART FAILURE; DAILY LIFE ACTIVITY; DIABETES MELLITUS; DISABLED PERSON; DRUG USE; ELDERLY CARE; FEMALE; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HUMAN; MAJOR CLINICAL STUDY; MORBIDITY; NEOPLASM; OSTEOARTHRITIS; PHARMACOEPIDEMIOLOGY; PHYSICAL DISABILITY; PRESCRIPTION; PRIORITY JOURNAL; RISK FACTOR; SELF CARE; SELF REPORT; CROSS-SECTIONAL STUDY; FRAIL ELDERLY; INFORMATION PROCESSING; POLYPHARMACY; STATISTICS;

ACTIVITIES OF DAILY LIVING; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; DATA COLLECTION; DISABLED PERSONS; FEMALE; FRAIL ELDERLY; HUMANS; NONPRESCRIPTION DRUGS; PHARMACOEPIDEMIOLOGY; POLYPHARMACY; PRESCRIPTION DRUGS; RISK FACTORS;

EID: 77955483872     PISSN: 15435946     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjopharm.2010.06.003     Document Type: Article

References (29)

1. Hanlon JT, Schmader KE, Ruby CM, Weinberger M. Suboptimal prescribing in older inpatients and outpatients. J Am Geriatr Soc. 2001;49:200-209. (Pubitemid 32207229)
2. Vik SA, Maxwell CJ, Hogan DB. Measurement, correlates, and health outcomes of medication adherence among seniors. Ann Pharmacother. 2004;38:303- 312. (Pubitemid 38112246)
3. Gurwitz JH, Field TS, Harrold LR, et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA. 2003;289:1107- 1116. (Pubitemid 37430324)
4. Hajjar ER, Cafiero AC, Hanlon JT. Polypharmacy in elderly patients. Am J Geriatr Pharmacother. 2007;5:345-351.
5. Lopez-Torres HJ, Cerda Diaz R, Fernandez OC, et al. Factors associated with chronic drug consumption in the elderly [in Spanish]. Med Clin (Barc). 1997;108:572-576.
6. Chrischilles EA, Foley DJ, Wallace RB, et al. Use of medications by persons 65 and over: Data from the established populations for epidemiologic studies of the elderly. J Gerontol. 1992;47:M137-M144.
7. Wallsten SM, Sullivan RJ Jr, Hanlon JT, et al. Medication taking behaviors in the high- and low-functioning elderly: MacArthur field studies of successful aging. Ann Pharmacother. 1995;29:359-364.
8. Kaufman DW, Kelly JP, Rosenberg L, et al. Recent patterns of medication use in the ambulatory adult population of the United States: The Sloan survey. JAMA. 2002; 287:337-344. (Pubitemid 34251967)
9. Kronish IM, Federman AD, Morrison RS, Boal J. Medication utilization in an urban homebound population. J Gerontol A Biol Sci Med Sci. 2006;61:411-415.
10. Chrischilles E, Rubenstein L, Van Gilder R, et al. Risk factors for adverse drug events in older adults with mobility limitations in the community setting. J Am Geriatr Soc. 2007;55:29-34. (Pubitemid 46046225)
11. Simonsick EM, Maffeo CE, Rogers SK, et al. Methodology and feasibility of a home-based examination in disabled older women: The Women's Health and Aging Study. J Gerontol A Biol Sci Med Sci. 1997;52:M264-M274. (Pubitemid 27413627)
12. Guralnik JM, Fried LP, Simonsick EM, et al, eds. The Women's Health and Aging Study: Health and Social Characteristics of Older Women with Disability. NIH Pub. No. 95-4009. Bethesda, Md: National Institute on Aging; 1995. http://www.nia.nih.gov/HealthInformation/Publications/Reports/ WomensHealthAgingStudy.htm Accessed June 10, 2010.
13. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
14. Fried LP, Tangen CM, Walston J, et al, for the Cardiovascular Health Study Collaborative Research Group. Frailty in older adults: Evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56:M146-M156. (Pubitemid 32187141)
15. Onder G, Penninx BW, Lapuerta P, et al. Change in physical performance over time in older women: The Women's Health and Aging Study. J Gerontol A Biol Sci Med Sci. 2002;57:M289-M293. (Pubitemid 34464968)
16. Pahor M, Chrischilles EA, Guralnik JM, et al. Drug data coding and analysis in epidemiologic studies. Eur J Epidemiol. 1994;10:405-411. (Pubitemid 24339205)
17. Manning WG, Basu A, Mullahy J. Generalized modeling approaches to risk adjustment of skewed outcomes data. J Health Econ. 2005;24:465-488. (Pubitemid 40461909)
18. Anis AH, Lynd LD, Wang XH, et al. Double trouble: Impact of inappropriate use of asthma medication on the use of health care resources. CMAJ. 2001;164:625- 631. (Pubitemid 32193861)
19. Boyd CM, Darer J, Boult C, et al. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: Implications for pay for performance. JAMA. 2005;294:716-724. (Pubitemid 41159291)
20. Espino DV, Bazaldua OV, Palmer RF, et al. Suboptimal medication use and mortality in an older adult community-based cohort: Results from the Hispanic EPESE Study. J Gerontol A Biol Sci Med Sci. 2006;61: 170-175. (Pubitemid 43334613)
21. Wynne HA, Yelland C, Cope LH, et al. The association of age and frailty with pharmacokinetics and pharmacodynamics of metoclopramide. Age Ageing. 1993;22: 354-359. (Pubitemid 23282362)
22. Kinirons MT, O'Mahony MS. Drug metabolism and ageing. Br J Clin Pharmacol. 2004;57:540-544. (Pubitemid 38582172)
23. Fried LP, Hadley EC, Walston JD, et al. From bedside to bench: Research agenda for frailty [published correction appears in Sci Aging Knowledge Environ. 2005;2005:er3]. Sci Aging Knowledge Environ. 2005;2005:pe24.
24. Ryan EA, Pick ME, Marceau C. Use of alternative medicines in diabetes mellitus. Diabet Med. 2001;18:242- 245. (Pubitemid 32397864)
25. Fillenbaum GG, Hanlon JT, Corder EH, et al. Prescription and nonprescription drug use among black and white community-residing elderly. Am J Public Health. 1993;83:1577-1582. (Pubitemid 23320043)
26. Orfila F, Ferrer M, Lamarca R, et al. Gender differences in health-related quality of life among the elderly: The role of objective functional capacity and chronic conditions. Soc Sci Med. 2006;63:2367-2380. (Pubitemid 44374824)
27. Evans RS, Lloyd JF, Stoddard GJ, et al. Risk factors for adverse drug events: A 10-year analysis. Ann Pharmacother. 2005;39:1161-1168. (Pubitemid 40943163)
28. Linton A, Garber M, Fagan NK, Peterson MR. Examination of multiple medication use among TRICARE beneficiaries aged 65 years and older. J Manag Care Pharm. 2007;13:155-162. (Pubitemid 46487936)
29. Centers for Medicare & Medicaid Services (CMS), HHS. Medicare program; Medicare prescription drug benefit; Final rule. Fed Regist. 2005;70:4193-4585.